Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia

Bone Marrow Transplant. 2020 Jun;55(6):1206-1208. doi: 10.1038/s41409-019-0677-z. Epub 2019 Sep 18.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Decitabine / therapeutic use
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, Myeloid, Acute* / therapy
  • Recurrence
  • Transplantation, Homologous

Substances

  • Decitabine